| Common Name |
Valyl-Proline
| Description |
Valyl-Proline is a dipeptide composed of valine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
| Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Structure for HMDB29135 (Valyl-Proline)
| Synonyms |
| Value |
Source |
L-Valyl-L-prolineHMDB
V-P DipeptideHMDB
Val-proHMDB
Valine proline dipeptideHMDB
Valine-proline dipeptideHMDB
ValylprolineHMDB
VP DipeptideHMDB
| Chemical Formlia |
C10H18N2O3
| Average Molecliar Weight |
214.2615
| Monoisotopic Molecliar Weight |
214.131742452
| IUPAC Name |
1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carboxylic acid
| Traditional Name |
1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carboxylic acid
| CAS Registry Number |
Not Available
| SMILES |
CC(C)C(N)C(=O)N1CCCC1C(O)=O
| InChI Identifier |
InChI=1S/C10H18N2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8H,3-5,11H2,1-2H3,(H,14,15)
| InChI Key |
GIAZPLMMQOERPN-UHFFFAOYSA-N
| Chemical Taxonomy |
| Description |
This compound belongs to the class of chemical entities known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
| Kingdom |
Chemical entities
| Super Class |
Organic compounds
| Class |
Organic acids and derivatives
| Sub Class |
Carboxylic acids and derivatives
| Direct Parent |
Dipeptides
| Alternative Parents |
N-acyl-alpha amino acids
Proline and derivatives
Valine and derivatives
Alpha amino acid amides
N-acylpyrrolidines
Pyrrolidine carboxylic acids
Tertiary carboxylic acid amides
Amino acids
Monocarboxylic acids and derivatives
Carboxylic acids
Azacyclic compounds
Organopnictogen compounds
Organic oxides
Monoalkylamines
Hydrocarbon derivatives
Carbonyl compounds
| Substituents |
Alpha-dipeptide
N-acyl-alpha amino acid or derivatives
N-acyl-alpha-amino acid
Valine or derivatives
Proline or derivatives
Alpha-amino acid amide
Alpha-amino acid or derivatives
N-acylpyrrolidine
Pyrrolidine carboxylic acid
Pyrrolidine carboxylic acid or derivatives
Tertiary carboxylic acid amide
Pyrrolidine
Carboxamide group
Amino acid or derivatives
Amino acid
Organoheterocyclic compound
Monocarboxylic acid or derivatives
Azacycle
Carboxylic acid
Organic nitrogen compound
Organonitrogen compound
Organooxygen compound
Primary amine
Primary aliphatic amine
Hydrocarbon derivative
Organic oxide
Carbonyl group
Organopnictogen compound
Amine
Organic oxygen compound
Aliphatic heteromonocyclic compound
| Molecliar Framework |
Aliphatic heteromonocyclic compounds
| External Descriptors |
Not Available
| Ontology |
| Status |
Expected but not Quantified
| Origin |
Endogenous
| Biofunction |
Not Available
| Application |
Not Available
| Cellliar locations |
Not Available
| Physical Properties |
| State |
Solid
| Experimental Properties |
| Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-2.22Extrapolated
| Predicted Properties |
| Property |
Value |
Source |
Water Solubility103.0 mg/mLALOGPS
logP-0.78ALOGPS
logP-2.2ChemAxon
logS-0.32ALOGPS
pKa (Strongest Acidic)3.86ChemAxon
pKa (Strongest Basic)8.51ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area83.63 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity54.48 m3·mol-1ChemAxon
Polarizability22.51 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
| Spectra |
| Spectra |
Not Available
| Biological Properties |
| Cellliar Locations |
Not Available
| Biofluid Locations |
Not Available
| Tissue Location |
Not Available
| Pathways |
Not Available
| Normal Concentrations |
| Not Available |
| Abnormal Concentrations |
|
Not Available
| Associated Disorders and Diseases |
| Disease References |
None
| Associated OMIM IDs |
None
| External Links |
| DrugBank ID |
Not Available
| DrugBank Metabolite ID |
Not Available
| Phenol Explorer Compound ID |
Not Available
| Phenol Explorer Metabolite ID |
Not Available
| FoodDB ID |
Not Available
| KNApSAcK ID |
Not Available
| Chemspider ID |
Not Available
| KEGG Compound ID |
Not Available
| BioCyc ID |
Not Available
| BiGG ID |
Not Available
| Wikipedia Link |
Not Available
| NuGOwiki Link |
HMDB29135
| Metagene Link |
HMDB29135
| METLIN ID |
Not Available
| PubChem Compound |
Not Available
| PDB ID |
Not Available
| ChEBI ID |
Not Available
Product: Tanshinone I
References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available |
| General References |
- Kruszewska H, Zareba T, Tyski S: Examination of antimicrobial activity of selected non-antibiotic medicinal preparations. Acta Pol Pharm. 2012 Nov-Dec;69(6):1368-71. [PubMed:23285704 ]
- Moczar M, David P, Loisance D: Vascular substitute from human placental arteries: glycosaminoglycan and elastin synthesis in the neo-intimal hyperplasia. Life Support Syst. 1984 Jul-Sep;2(3):201-8. [PubMed:6503349 ]
- Sjolund M, Madsen K, von der Mark K, Thyberg J: Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. Differentiation. 1986;32(2):173-80. [PubMed:3539683 ]
|
PMID: 22384002
